Tamoxifen
#
Find similar titles
- (rev. 2)
- Hyungyong Kim
Structured data
Tamoxifen is an antagonist of the Estrogen receptor in breast tissue via its active metabolite, 4-hydroxytamoxifen.
Tamoxifen is the usual endocrine (anti-estrogen) therapy for ER+ Breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting.
관련링크
Table of Contents
Incoming Links #
Related Medical Conditions (MedicalCondition 0) #
Related Articles (Article 1) #
Related Books (Book 2) #
Related Codes (Code 3) #
Related Medical Scholarly Articles (MedicalScholarlyArticle 4) #
Suggested Pages #
- 0.050 BRCA2
- 0.048 Cytokeratin
- 0.046 Trastuzumab
- 0.030 CDK12
- 0.030 HMEC
- 0.027 Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
- 0.025 PyCon Korea 2014
- 0.025 Endoplasmic reticulum
- 0.025 Comprehensive molecular portraits of human breast tumours
- 0.025 HER2
- More suggestions...